Stephanie Nolen

@stephanienolen.bsky.social

Global health reporter, The New York Times. Former correspondent in South Asia, Africa, Latin America and the MidEast. Author, 28 Stories of AIDS in Africa; Promised the Moon. Baker. Canoe tripper. Disease nerd. Lover of a fat novel and Earl Grey tea.

@moiradonegan.bsky.socialReposted by @stephanienolen.bsky.social

I also appreciate Emily Wilson as a woman in a male dominated role, by which I don’t mean translator or classicist or public scholar but rather “curmudgeon.”

@brbarrett.bsky.socialReposted by @stephanienolen.bsky.social

Ebay’s harassment spree against a perfectly nice couple in Massachusetts is one of the craziest stories I’ve ever covered. Six years later, the victims have finally gotten their due. from @laurengoode.bsky.social

wired.comEbay Has to Pay $55.7 Million in Settlement for Its Unhinged Harassment CampaignFor months on end, eBay employees and contractors made life hell for a couple that had criticized the company. Six years later, the company is finally paying up.
@gregfolkers.bsky.socialReposted by @stephanienolen.bsky.social

NYT: With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access

By Stephanie Nolen @nytimes.com @stephanienolen.bsky.social

nyti.ms/4h07K3i

nyti.msWith Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure AccessCompanies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains...
@pbleic.bsky.socialReposted by @stephanienolen.bsky.social

Astonishing. RFK Jr. adds 8 members to a 6 member FDA advisory panel. 6 of them were sellers of peptides, and the 7th a compounding pharmacist. In an 8-6 vote with all 8 votes coming from these new panel members, the panel approved 4 peptides against the objections of FDA scientists.

nytimes.comFDA Panel Supports Lifting Restrictions on Four Peptides (Gift Article)In an all-day hearing, the agency’s scientists argued against allowing broad access to unproven drugs that the agency had banned three years ago.
@picardonhealth.bsky.socialReposted by @stephanienolen.bsky.social

How Bad Could the Ebola Outbreak Get? Here Are 5 Key Factors. Contact tracing is improving. Treatments may be months away. Here’s what could determine whether a fast-expanding outbreak can be slowed down. www.nytimes.com/interactive/... via @nytimes.com @stephanienolen.bsky.social

nytimes.comHow Bad Could the Ebola Outbreak Get? Latest on Testing, Tracing and VaccinesContact tracing is improving. Treatments may be months away. Here’s what could determine whether a fast-expanding outbreak can be slowed down.
@publichealthguy1.bsky.socialReposted by @stephanienolen.bsky.social

appreciate @stephanienolen.bsky.social and @carlzimmer.com ending the article with this important history on ebola drug access

In 2019, during an Ebola outbreak in Congo, a trial funded largely by the U.S. National Institutes of Health tested four monoclonal antibodies treatments. Two of the drugs cut deaths in patients by as much as 50 percent. One of them was developed from the blood of a Congolese Ebola survivor. And yet, despite the public funding and the local origin of the treatments, there was no guarantee that the promising drugs would be supplied in Congo. Two companies, Regeneron and Ridgeback Biotherapeutics, ended up holding the intellectual property. Neither registered either drug in any of the countries where Ebola outbreaks occur. Instead, the U.S. government bought the entire supply of both drugs for its own national security stockpile.
Carl Zimmer@carlzimmer.com

As the Bundibugyo outbreak continues to grow, researchers are scrambling to start clinical trials of antivirals and monoclonal antibodies to see if any work against the virus. Here's my story on the race, with @stephanienolen.bsky.social Gift link: nyti.ms/4eEZHqR

nyti.ms
@amandamull.bsky.socialReposted by @stephanienolen.bsky.social

Incredibly proud of my @bloomberg.com colleagues, who won a Pulitzer today for illustrated reporting for the graphic novel version of an incredible, harrowing story about “digital arrest” scams in India. Gift link to the graphic novel, will thread the feature below: www.bloomberg.com/graphics/202...

bloomberg.comArrested by Phone: A Graphic NovelNo texting. No visitors. No escape. She was caught in India’s new digital nightmare.
Older posts